铁死亡促进常染色体显性多囊肾病小鼠模型的囊肿生长
该研究探讨铁死亡在常染色体显性多囊肾病(ADPKD)中的作用。在Pkd1突变细胞和小鼠模型中,Pkd1缺失导致铁代谢异常和铁死亡倾向;铁死亡诱导剂erastin加重、抑制剂ferrostatin-1减轻细胞死亡和囊肿生长;脂质过氧化产物4HNE通过激活Akt等通路促进存活细胞增殖。
要点
- Pkd1缺失导致铁死亡相关代谢异常和铁死亡倾向。
- erastin加重、ferrostatin-1减轻Pkd1缺陷细胞的铁死亡和增殖。
- 4HNE通过激活Akt等通路促进存活细胞增殖参与囊肿生长。
核心结论
- 铁死亡促进ADPKD进展,管理铁死亡可能是ADPKD治疗新策略。
研究设计与样本
- 研究使用Pkd1突变肾细胞和组织及Pkd1突变小鼠模型,采用Western blot和qRT-PCR分析。
主要发现
- Pkd1缺失细胞和组织中system Xc-、ferroportin和GPX4表达降低,TfR1、DMT1和HO-1表达增加。
- 上述改变导致铁水平高、GSH和GPX4活性低、脂质过氧化增加和铁死亡倾向。
- erastin增加、ferrostatin-1抑制Pkd1缺陷细胞的铁死亡和增殖。
- 4HNE通过激活Akt、S6、Stat3和Rb促进存活Pkd1突变细胞增殖,参与囊肿生长。
临床怎么用
- 铁死亡可能成为ADPKD治疗的新靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD), the most common inherited kidney disease, is regulated by different forms of cell death, including apoptosis and autophagy. However, the role in ADPKD of ferroptosis, a recently discovered form of cell death mediated by iron and lipid metabolism, remains elusive. METHODS: To determine a pathophysiologic role of ferroptosis in ADPKD, we investigated whether the absence of Pkd1 (encoding polycystin-1) affected the expression of key factors involved in the process of ferroptosis, using Western blot and qRT-PCR analysis in Pkd1 mutant renal cells and tissues. We also examined whether treatment with erastin, a ferroptosis inducer, and ferrostain-1, a ferroptosis inhibitor, affected cyst growth in Pkd1 mutant mouse models. RESULTS: We found that kidney cells and tissues lacking Pkd1 exhibit extensive metabolic abnormalities, including reduced expression of the system Xc- amino acid antiporter (critical for import of cystine), of iron exporter (ferroportin), and of GPX4 (a key and negative regulator of ferroptosis). The abnormalities also include increased expression of iron importers (TfR1, DMT1) and HO-1, which in turn result in high iron levels, low GSH and GPX4 activity, increased lipid peroxidation, and propensity to ferroptosis. We further found that erastin increased, and ferrostatin-1 inhibited ferroptotic cell death and proliferation of Pkd1-deficient cells in kidneys from Pkd1 mutant mice. A lipid peroxidation product increased in Pkd1-deficient cells, 4HNE, promoted the proliferation of survived Pkd1 mutant cells via activation of Akt, S6, Stat3, and Rb during the ferroptotic process, contributing to cyst growth. CONCLUSION: These findings indicate that ferroptosis contributes to ADPKD progression and management of ferroptosis may be a novel strategy for ADPKD treatment.
引用
- Zhang X, Li LX, Ding H, et al. Ferroptosis Promotes Cyst Growth in Autosomal Dominant Polycystic Kidney Disease Mouse Models. J Am Soc Nephrol. 2021. PMID: 34716241. doi:10.1681/ASN.2021040460
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。